Clinical Trial for Prostate Cancer Patients

Last updated: 05/19/2006

The Edwards Comprehensive Cancer Center is taking part in a national clinical research study of an investigational prostate cancer immunotherapy.

This study team is seeking men with advance prostate cancer or physicians treating patients with metastatic hormone-refractory prostate cancer. A man may qualify to participate in this research study if:

the cancer has spread to his bones or elsewhere in his body.
he has been treated with hormone therapy and it has stopped working.

If you or someone you know has been treated with hormone therapy for metastatic hormone-refractory prostate cancer and are seeking information on clinical trial options, please call Dr. Maria Tirona at (304) 399-6617.